{"title":"Proception vs Sharpa: Manipulation compared","url":"https://www.frontiertechintelligence.com/compare/proception-vs-sharpa","comparison":"Sharpa ranks 11 on the Humanoids 100 with a score of 84; Proception ranks 97 with 51. Sharpa is ahead on deployment, production, commercials, progress, technology, positioning, firepower and leverage. Proception is based in United States, Sharpa in Singapore, Singapore. Sharpa: private. Proception is named in 9 signals and Sharpa in 85.","companies":[{"name":"Proception","url":"https://www.frontiertechintelligence.com/companies/proception","city":null,"country":"United States","stage":null,"founded":null,"last_round":null,"positioning":"Proception is a US humanoid-robotics component maker developing ProHand 1.0, a 22-DoF tendon-driven dexterous hand, and ProGlove, a wearable tactile-data system for robot-learning workflows. It publicly launched and began shipping its first batch to researchers and robotics companies on Jun-29-26, alongside an $11M seed led by First Round Capital with Y Combinator and BoxGroup; subsequent company activity indicates customer use and additional ProGlove sales. Its distinguishing bet is that humanoid builders will buy dexterous hands rather than develop them internally, but deployment scale, independent validation, named customers, and revenue remain unverified.","assessed_in":{"domain":"Humanoids","list":"Humanoids 100","rank":97,"score":51,"tier":"member","scores":{"gate_ne":["firepower"],"leverage":4,"position":6,"progress":8,"firepower":4,"commercial":3,"deployment":4,"production":4,"technology":6},"why":"Proception develops and sells ProHand, a dexterous tendon-driven robotic hand designed for humanoid and robotics applications. Its product is a manipulation component with integrated tactile sensing.","segment":"Manipulation","layer":"Components"},"signals_total":9,"facts_total":26},{"name":"Sharpa","url":"https://www.frontiertechintelligence.com/companies/sharpa","city":"Singapore","country":"Singapore","stage":"private","founded":null,"last_round":null,"positioning":"Sharpa (Singapore HQ, Shanghai manufacturing) is a self-described unicorn (founded 2024) making the SharpaWave dexterous hand (22 active DoF, >1,000 tactile pixels per fingertip, ~$50,000 per hand) in mass production since October 2025, plus the North full-body robot shown at CES 2026. Its reference-design win is decisive: NVIDIA's Isaac GR00T Reference Humanoid (Computex 2026) is built on a Unitree H2 chassis with Sharpa Wave hands, the first dexterous reference design on the GR00T platform, with lab partners including NVIDIA, Google, MIT, and Stanford. Revenue is estimated at 10-100m (early orders from global technology firms).","assessed_in":{"domain":"Humanoids","list":"Humanoids 100","rank":11,"score":84,"tier":"member","scores":{"leverage":10,"position":8,"progress":10,"firepower":7,"commercial":6,"deployment":7,"production":8,"technology":10},"why":"Sharpa sells North, a general-purpose humanoid robot, to enterprise operators for autonomous service and dexterous manipulation.","segment":"Manipulation","layer":"Components"},"signals_total":85,"facts_total":78}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}